Anastasia Georgiadi - Helmholtz Munich

Head of Junior Group Endocrine Pharmacology, Institute of Diabetes and Cancer (IDC)

+49 89 3187 1808 Email meBuilding/Room: 3620

Visit my Lab Page

Professional Background

Since 2021

Group Leader, Institute for Diabetes and Cancer, Helmholtz Diabetes Centre, Munich

2018 - 2021

Project Team Leader, Institute for Diabetes and Cancer, Helmholtz Diabetes Centre, Munich

2015 - 2018

Postdoctoral fellow, Department of Adipose Tissue Biology, Institute for Diabetes and Cancer, Helmholtz Diabetes Centre, Munich

2012 - 2015

Postdoctoral fellow, Department of Cell and Molecular Biology, Karolinska Institute, Sweden

Honors and Awards

Since 2018 - EFSD/Lilly Award
2012 - Rubicon Postdoctoral Mobility Fellowship, The Netherlands Organisation for Scientific Research (NWO)

Gold Star Awards Luxury Background

Nature Communications

Georgiadi A ... Herzig S. - 2021

Orphan GPR116 mediates the insulin sensitizing effects of the hepatokine FNDC4 in adipose tissue.

Mol Aspects Med

Klepac K, Georgiadi A, Tschöp M, Herzig S - 2019

The role of brown and beige adipose tissue in glycaemic control.

Proc Natl Acad Sci

Duteil D, Tosic M, Willmann D, Georgiadi A, Kanouni T, Schüle R. - 2017

Lsd1 prevents age-programed loss of beige adipocytes.

Horm Mol Biol Clin Investig

Scheideler M, Herzig S, Georgiadi A. - 2017

Endocrine and autocrine/paracrine modulators of brown adipose tissue mass and activity as novel therapeutic strategies against obesity and type 2 diabetes.

Nature Communications

Bosma M, Gerling M, Pasto J, Georgiadi A, ... Boström PA. - 2016

FNDC4 acts as an anti-inflammatory factor on macrophages and improves colitis in mice.